956017-55-3

Upstream product

• 1099821-38-1 5-[3-((1R,2S,3R,5R)-3-(tert-butyl-dimethyl-silanyloxy)-5-chloro-2-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester 
• 956017-50-8 5-[3-((1S,5S)-5-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-4-oxo-cyclopent-2-enyl)-propyl]-thiophene-2-carboxylic acid methyl ester 
• 956017-49-5 5-[3-((1R,2S,3R,5R)-5-Chloro-3-hydroxy-2-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester 
• 1042168-25-1 5-[3-((1S,2S)-2-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-3-oxo-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester TBS hydrazone 
• 956017-51-9 5-[3-((1S,2S)-2-{4-[1-(4-Methoxy-benzyloxy)-hexyl]-phenyl}-3-oxo-cyclopentyl)-propyl]-thiophene-2-carboxylic acid methyl ester 

Downstream Products

• 1042168-81-9 C₃₄H₄₁ClO₄S 
• 1042168-28-4 5-[3-((S)-3-chloro-2-{4-[1-(4-methoxy-benzyloxy)-hexyl]-phenyl}-cyclopent-2-enyl)-propyl]-thiophene-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS

Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J, B, Y, and A are as described in claims 1-13. Methods, compositions, and medicaments related thereto are also disclosed, for treating baldness, glauco

SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS

Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein Y, A, and B are as described. Methods, compositions, and medicaments related thereto are also disclosed.

SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS

Disclosed herein is a compound of the formula (I). Therapeutic methods, compositions, and medicaments, related thereto are also disclosed.

THERAPEUTIC COMPOUNDS

A compound having a structure is disclosed herein. Compositions, medicaments, and therapeutic methods related thereto are also disclosed.